Structural Features and Properties of Metal Complexes in Ionic Liquids: Application in Alkylation Reactions

Metal-containing ionic liquids (ILs) represent a promising sub-class of “charged” liquids which increase the tunability of ILs combining the properties of common organic salts with magnetic, photophysical/optical or catalytic properties of the incorporated metal salts. In ILs lacking of coordinating groups on cation dissolution of metal salts is generally associated with the coordination of the metal cation with IL anion(s). Here we report on the anionic speciation of metals in ILs having either highly or poorly coordinating anions and we discuss some peculiar properties of these systems in the light of their structural features

Dissolution of metal salts in bis(trifluoromethylsulfonyl)imide-based ionic liquids: Studying the affinity of metal cations toward a "weakly coordinating" anion

Despite the weakly coordinating ability of the bis(trifluoromethylsulfonyl)imide anion ([Tf2N]-) the corresponding ionic liquids (ILs) are able to dissolve relevant amounts of metal salts having the same anion, M[Tf2N]x. To better understand the metal dissolution process we evaluated the interaction ability of a set of metal cations (Y(III), Al(III), Co(II), Ni(II), Cu(II), Zn(II), Ag(I), Li(I), and Na(I)) toward the [Tf2N]- anion measuring the relative aptitude to give the corresponding anionic monocharged complex, [M(Tf2N)x+1]- using the ESI-MS technique. UV-vis and NMR measurements were carried out to verify the consistence between the liquid and the gas phase. Density functional theory calculations have been used to identify the metal-containing species and determine their relative stability. An interesting correlation between interaction ability and chemical properties (Lewis acidity) was found

Alkylation of methyl linoleate with propene in ionic liquids in the presence of metal salts

Vegetable oils and fatty acid esters are suitable precursor molecules for the production of a variety of bio-based products and materials, such as paints and coatings, plastics, soaps, lubricants, cosmetics, pharmaceuticals, printing inks, surfactants, and biofuels. Here, we report the possibility of using Lewis acidic ionic liquids (ILs) to obtain polyunsaturated ester dimerization-oligomerization and/or, in the presence of another terminal alkene (propene), co-polymerization. In particular, we have tested the Lewis acidic mixtures arising from the addition of a proper amount of GaCl3 (X > 0.5) to two chloride-based (1-butyl-3-methylimidazolium chloride, [bmim]Cl, and 1-butylisoquinolium chloride, [BuIsoq]Cl) or by dissolution of a smaller amount of Al(Tf2N)3 (X = 0.1) in 1-butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide, [bmim][Tf2N]. On the basis of product distribution studies, [bmim][Tf2N]/Al(Tf2N)3 appears the most suitable medium in which methyl linoleate alkylation with propene can compete with methyl linoleate or propene oligomerization

ITALIAN CANCER FIGURES - REPORT 2015: The burden of rare cancers in Italy = I TUMORI IN ITALIA - RAPPORTO 2015: I tumori rari in Italia

OBJECTIVES: This collaborative study, based on data collected by the network of Italian Cancer Registries (AIRTUM), describes the burden of rare cancers in Italy. Estimated number of new rare cancer cases yearly diagnosed (incidence), proportion of patients alive after diagnosis (survival), and estimated number of people still alive after a new cancer diagnosis (prevalence) are provided for about 200 different cancer entities. MATERIALS AND METHODS: Data herein presented were provided by AIRTUM population- based cancer registries (CRs), covering nowadays 52% of the Italian population. This monograph uses the AIRTUM database (January 2015), which includes all malignant cancer cases diagnosed between 1976 and 2010. All cases are coded according to the International Classification of Diseases for Oncology (ICD-O-3). Data underwent standard quality checks (described in the AIRTUM data management protocol) and were checked against rare-cancer specific quality indicators proposed and published by RARECARE and HAEMACARE (www.rarecarenet.eu; www.haemacare.eu). The definition and list of rare cancers proposed by the RARECAREnet "Information Network on Rare Cancers" project were adopted: rare cancers are entities (defined as a combination of topographical and morphological codes of the ICD-O-3) having an incidence rate of less than 6 per 100,000 per year in the European population. This monograph presents 198 rare cancers grouped in 14 major groups. Crude incidence rates were estimated as the number of all new cancers occurring in 2000-2010 divided by the overall population at risk, for males and females (also for gender-specific tumours).The proportion of rare cancers out of the total cancers (rare and common) by site was also calculated. Incidence rates by sex and age are reported. The expected number of new cases in 2015 in Italy was estimated assuming the incidence in Italy to be the same as in the AIRTUM area. One- and 5-year relative survival estimates of cases aged 0-99 years diagnosed between 2000 and 2008 in the AIRTUM database, and followed up to 31 December 2009, were calculated using complete cohort survival analysis. To estimate the observed prevalence in Italy, incidence and follow-up data from 11 CRs for the period 1992-2006 were used, with a prevalence index date of 1 January 2007. Observed prevalence in the general population was disentangled by time prior to the reference date (≤2 years, 2-5 years, ≤15 years). To calculate the complete prevalence proportion at 1 January 2007 in Italy, the 15-year observed prevalence was corrected by the completeness index, in order to account for those cancer survivors diagnosed before the cancer registry activity started. The completeness index by cancer and age was obtained by means of statistical regression models, using incidence and survival data available in the European RARECAREnet data. RESULTS: In total, 339,403 tumours were included in the incidence analysis. The annual incidence rate (IR) of all 198 rare cancers in the period 2000-2010 was 147 per 100,000 per year, corresponding to about 89,000 new diagnoses in Italy each year, accounting for 25% of all cancer. Five cancers, rare at European level, were not rare in Italy because their IR was higher than 6 per 100,000; these tumours were: diffuse large B-cell lymphoma and squamous cell carcinoma of larynx (whose IRs in Italy were 7 per 100,000), multiple myeloma (IR: 8 per 100,000), hepatocellular carcinoma (IR: 9 per 100,000) and carcinoma of thyroid gland (IR: 14 per 100,000). Among the remaining 193 rare cancers, more than two thirds (No. 139) had an annual IR <0.5 per 100,000, accounting for about 7,100 new cancers cases; for 25 cancer types, the IR ranged between 0.5 and 1 per 100,000, accounting for about 10,000 new diagnoses; while for 29 cancer types the IR was between 1 and 6 per 100,000, accounting for about 41,000 new cancer cases. Among all rare cancers diagnosed in Italy, 7% were rare haematological diseases (IR: 41 per 100,000), 18% were solid rare cancers. Among the latter, the rare epithelial tumours of the digestive system were the most common (23%, IR: 26 per 100,000), followed by epithelial tumours of head and neck (17%, IR: 19) and rare cancers of the female genital system (17%, IR: 17), endocrine tumours (13% including thyroid carcinomas and less than 1% with an IR of 0.4 excluding thyroid carcinomas), sarcomas (8%, IR: 9 per 100,000), central nervous system tumours and rare epithelial tumours of the thoracic cavity (5%with an IR equal to 6 and 5 per 100,000, respectively). The remaining (rare male genital tumours, IR: 4 per 100,000; tumours of eye, IR: 0.7 per 100,000; neuroendocrine tumours, IR: 4 per 100,000; embryonal tumours, IR: 0.4 per 100,000; rare skin tumours and malignant melanoma of mucosae, IR: 0.8 per 100,000) each constituted <4% of all solid rare cancers. Patients with rare cancers were on average younger than those with common cancers. Essentially, all childhood cancers were rare, while after age 40 years, the common cancers (breast, prostate, colon, rectum, and lung) became increasingly more frequent. For 254,821 rare cancers diagnosed in 2000-2008, 5-year RS was on average 55%, lower than the corresponding figures for patients with common cancers (68%). RS was lower for rare cancers than for common cancers at 1 year and continued to diverge up to 3 years, while the gap remained constant from 3 to 5 years after diagnosis. For rare and common cancers, survival decreased with increasing age. Five-year RS was similar and high for both rare and common cancers up to 54 years; it decreased with age, especially after 54 years, with the elderly (75+ years) having a 37% and 20% lower survival than those aged 55-64 years for rare and common cancers, respectively. We estimated that about 900,000 people were alive in Italy with a previous diagnosis of a rare cancer in 2010 (prevalence). The highest prevalence was observed for rare haematological diseases (278 per 100,000) and rare tumours of the female genital system (265 per 100,000). Very low prevalence (<10 prt 100,000) was observed for rare epithelial skin cancers, for rare epithelial tumours of the digestive system and rare epithelial tumours of the thoracic cavity. COMMENTS: One in four cancers cases diagnosed in Italy is a rare cancer, in agreement with estimates of 24% calculated in Europe overall. In Italy, the group of all rare cancers combined, include 5 cancer types with an IR>6 per 100,000 in Italy, in particular thyroid cancer (IR: 14 per 100,000).The exclusion of thyroid carcinoma from rare cancers reduces the proportion of them in Italy in 2010 to 22%. Differences in incidence across population can be due to the different distribution of risk factors (whether environmental, lifestyle, occupational, or genetic), heterogeneous diagnostic intensity activity, as well as different diagnostic capacity; moreover heterogeneity in accuracy of registration may determine some minor differences in the account of rare cancers. Rare cancers had worse prognosis than common cancers at 1, 3, and 5 years from diagnosis. Differences between rare and common cancers were small 1 year after diagnosis, but survival for rare cancers declined more markedly thereafter, consistent with the idea that treatments for rare cancers are less effective than those for common cancers. However, differences in stage at diagnosis could not be excluded, as 1- and 3-year RS for rare cancers was lower than the corresponding figures for common cancers. Moreover, rare cancers include many cancer entities with a bad prognosis (5-year RS <50%): cancer of head and neck, oesophagus, small intestine, ovary, brain, biliary tract, liver, pleura, multiple myeloma, acute myeloid and lymphatic leukaemia; in contrast, most common cancer cases are breast, prostate, and colorectal cancers, which have a good prognosis. The high prevalence observed for rare haematological diseases and rare tumours of the female genital system is due to their high incidence (the majority of haematological diseases are rare and gynaecological cancers added up to fairly high incidence rates) and relatively good prognosis. The low prevalence of rare epithelial tumours of the digestive system was due to the low survival rates of the majority of tumours included in this group (oesophagus, stomach, small intestine, pancreas, and liver), regardless of the high incidence rate of rare epithelial cancers of these sites. This AIRTUM study confirms that rare cancers are a major public health problem in Italy and provides quantitative estimations, for the first time in Italy, to a problem long known to exist. This monograph provides detailed epidemiologic indicators for almost 200 rare cancers, the majority of which (72%) are very rare (IR<0.5 per 100,000). These data are of major interest for different stakeholders. Health care planners can find useful information herein to properly plan and think of how to reorganise health care services. Researchers now have numbers to design clinical trials considering alternative study designs and statistical approaches. Population-based cancer registries with good quality data are the best source of information to describe the rare cancer burden in a population

Comportamento di Metalli e Sali di Metalli nei Liquidi Ionici

L’obiettivo principale del presente lavoro di tesi era lo studio del comportamento di miscele di liquidi ionici - sali inorganici al fine di ottenere soluzioni concentrate di cationi metallici in liquidi ionici, definibili anche come miscele ternarie o quaternarie, da utilizzare sia come tali, come solventi con attività catalitica in reazioni organiche, che come soluzioni “madre” per generare nanoparticelle di dimensioni controllate in ambiente acquoso. La prima parte del lavoro è stata dedicata alla preparazione di nuovi liquidi ionici funzionalizzati a base imidazolo, associati a diversi cationi inorganici ed organici; alcuni dei quali con proprietà riducenti. I nuovi liquidi ionici sono stati completamente caratterizzati e sono state determinate le principali proprietà chimico-fisiche a diverse temperature. Ai nuovi liquidi ionici sono state addizionate quantità crescenti di opportuni sali metallici, ottenendo nella maggior parte dei casi nuovi liquidi ionici che sono stati completamente caratterizzati. Per alcuni metalli (Au e Co) è stata inoltre determinata la capacità del liquido ionico di funzionare da stabilizzante di nanoparticelle una volta che la miscela ionica è stata posta in acqua in condizioni riducenti. Le capacità stabilizzanti del liquido ionico e le caratteristiche delle nanoparticelle formate sono state valutate al variare della natura del riducente, della concentrazione del liquido ionico in acqua e del tempo

Aspetti psicologici della diagnosi ecografica di malformazioni e complicanze fetali. Il punto di vista del medico

Malformazioni e complicanze fetali rimandano al concetto pi\uf9 generale di \u201cgravidanze ad alto rischio\u201d, ovvero tutti quei casi in cui la madre e/o il feto hanno un rischio elevato di morbilit\ue0 o mortalit\ue0. Le condizioni pi\uf9 frequenti che possono essere incluse sotto questa definizione sono: rottura prematura delle membrane, ridotta crescita intrauterina, comparsa di infezioni che compromettono lo sviluppo del feto, preeclampsia, malformazioni del feto riscontrabili in epoca prenatale tramite apposite metodiche di indagine strumentale, anomalie cromosomiche o genetiche . Si tratta di quadri clinici eterogenei accomunati dal fatto che il medico si trova a dover operare delle scelte terapeutiche \u201cdifficili\u201d poich\ue9 spesso condizionate da conflitto di interessi madre \u2013 feto, implicazioni future in termini di qualit\ue0 di vita, necessit\ue0 di prendere decisioni in tempi relativamente stretti, prognosi indefinita, difficolt\ue0 nel comunicare aspetti complessi e/o dolorosi alla paziente, difficolt\ue0 nel coordinarsi con i vari professionisti implicati nella cura. L'esplorazione degli aspetti psicologici dal punto di vista del medico implica una duplice riflessione: da una parte, articolare quale sia il vissuto emotivo che pu\uf2 esperire il medico in questi casi; dall\u2019altra parte, descrivere le variabili che influenzano la condotta del medico cio\ue8 come decide e come comunica con la paziente

Dissolution of Metal Salts in Bis-(trifluoromethylsulfonyl)imide Based Ionic Liquids: Studying the Affinity of Metal Cations towards a “Weakly Coordinating” Anion

Despite the weakly coordinating ability of the bis(trifluoromethylsulfonyl)imide anion ([Tf2N]-) the corresponding ionic liquids (ILs) are able to dissolve relevant amounts of metal salts having the same anion, M[Tf2N]x. To better understand the metal dissolution process we evaluated the interaction ability of a set of metal cations (Y(III), Al(III), Co(II), Ni(II), Cu(II), Zn(II), Ag(I), Li(I), and Na(I)) toward the [Tf2N]- anion measuring the relative aptitude to give the corresponding anionic monocharged complex, [M(Tf2N)x+1]- using the ESI-MS technique. UV-vis and NMR measurements were carried out to verify the consistence between the liquid and the gas phase. Density functional theory calculations have been used to identify the metal-containing species and determine their relative stability. An interesting correlation between interaction ability and chemical properties (Lewis acidity) was found

Structural features and properties of metal complexes in ionic liquids: Application in alkylation reactions

Metal-containing ionic liquids (ILs) represent a promising sub-class of “charged” liquids which increase the tunability of ILs combining the properties of common organic salts with magnetic, photophysical/optical or catalytic properties of the incorporated metal salts. In ILs lacking of coordinating groups on cation dissolution of metal salts is generally associated with the coordination of the metal cation with IL anion(s). Here we report on the anionic speciation of metals in ILs having either highly or poorly coordinating anions and we discuss some peculiar properties of these systems in the light of their structural features